Leonteq AG (LEON)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 20.80 |
|---|---|
| 52-week range | 10.20 – 22.30 |
| Return, 1 month / 3 months | +2.5% / +32.5% |
| Return, 1 year / 3 years | +35.9% / −39.4% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 43.6% |
| Worst drawdown (1 year) | -32.2% |
| Average daily value traded | 0.82M CHF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Leonteq is a Swiss financial technology firm based in Zurich that builds and issues structured investment products. It runs a platform through which banks, asset managers and insurance companies design and issue their own products, and it also acts as an issuer itself. Its offerings include structured products linked to equities, rates and other assets, along with insurance-linked securities, serving financial institutions and their clients in Switzerland and other markets.
Leonteq AG trades under the code LEON on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Leonteq AG (LEON) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 20.80 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 63 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.9% and over the last three months it rose 32.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.0% | ||
| From 52-week high | -3.9% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 32.5% | ||
| 6-month return | 33.2% | ||
| 12-month return, skipping the last month | 32.7% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.2% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.82M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | +2.5% |
| 3 months | +32.5% |
| 6 months | +33.2% |
| 1 year | +35.9% |
| 3 years | −39.4% |
| 5 years | −60.7% |
Signals
| 50-day / 200-day average | 20.51 / 16.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Mar 2025 | CHF 1.5000 |
| 3 Apr 2024 | CHF 0.5000 |
| 3 Apr 2023 | CHF 2.0000 |
| 4 Apr 2022 | CHF 1.5000 |
| 6 Apr 2021 | CHF 0.3750 |
| 2 Apr 2020 | CHF 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.